We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Andrx, Watson Receive Second FTC Request for Information on Merger
Andrx, Watson Receive Second FTC Request for Information on Merger
May 3, 2006
Andrx and Watson Pharmaceuticals have received a second request from the FTC for additional information in connection with Watson’s impending purchase of Andrx, the companies said May 3.